Also, any choices from shuksan? sarah? missash? CSOakes? Wadigo? Gillett? Applefoot? beautifulplumage? DavidMN? DartthrowingMonkey?I'm still combing through ideas. :) But I'm sure about one (second to come soon).I'll take Optimer (OPTR).C-Diff hasn't been capturing headlines lately, but doesn't mean it won't later in 2010. Quite a journey from just a year or so ago when there was talk about sending some nurses and docs to jail for their roles in spreading it in Scotland.Watching for: partnerships plus second phase 3 for Fidaxomicin - due to report data in early 2010. If the second trial is as successful as the first trial, we intend to use these studies to support the filing of a new drug application, or NDA, for U.S. registration as soon as practical thereafter.http://www.optimerpharma.com/pipeline.asp?pipeline=1From my picks last year - SQNM worked out well, but I'm not sure it has as much juice left. ARRY - ehh - not again.I'll be back with a second one. Thanks!Sarah
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra